Synjardy 12.5 mg/1000 mg film-coated tablets
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Synjardy 12.5 mg/1000 mg film-coated tablets, covering 2025-05-23 to 2025-05-23. Get the full timeline:
Most recent: Clinical Trial Update: Pharmacokinetics and Bioequivalence Study of Empagliflozin+Metformin Hydrochloride 12.5 mg/1000 mg Film-coated Tablets (Gedeon Richter Plc., Hungary) Versus Synjardy 12.5 mg/1000 mg Film-coated Tablets (Boehringer Ingelheim International GmbH, Germany) [Phase 1]